GlassScriptPhysician profile
Chistopher J Rott
NPI 1114112539
$11,080.65
in general payments reported to CMS, 2019-2025
13 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $2,085 · 2021: $616 · 2022: $1,845 · 2023: $2,409 · 2024: $1,958 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,584 · Food and Beverage: $2,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,583.78 |
| Food and Beverage | $2,108.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $4,956.61 | 2019-2025 | Attune, Velys, Healix Knotless Peek |
| Stryker Corporation | $2,031.57 | 2021-2025 | Gamma, Adapt, T2 |
| Medical Device Business Services, INC. | $2,011.23 | 2020-2025 | Attune, Velys |
| Gemini Medical LLC | $762.75 | 2019 | |
| Arthrex, INC. | $666.50 | 2019 | |
| Orthalign INC | $195.12 | 2023 | Orthalign Plus |
| Bone Support INC. | $144.91 | 2024 | Ceramentbone Void Filler, Cerament G |
| Innovation Technologies INC | $131.81 | 2023 | Irrisept |
| Zimmer Biomet Holdings, INC. | $95.72 | 2019-2020 | |
| Medtronic, INC. | $33.29 | 2024 | Aquamantys(Tm) |
| Abbott Laboratories | $21.00 | 2023 | Jot Dx |
| Sanofi-Aventis U.S. LLC | $15.11 | 2023 | |
| Amgen INC. | $15.03 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chistopher Rott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.